openPR Logo
Press release

Anticholinergic Drugs Market by Application, Trends and Growth Rate to 2025

02-23-2018 10:05 AM CET | Health & Medicine

Press release from: Transparency Market Research

Anticholinergic Drugs Market by Application, Trends and Growth

Nephrology and urology disorders are common complications of cardiovascular diseases and diabetes. Certain drugs and unhealthy food habits are also known to cause nephrological and urological diseases. According to the National Institute of Diabetes and Digestive & Kidney Diseases approximately 26 million individuals in the U.S. suffer from chronic kidney diseases. Statistics also shows that about 87,000 patients die of kidney failure every year. Some of the commonly used drug classes for treating nephrological and urological disorders include diuretics, anti-hypertensive drugs, phosphate binders, and anti-cholinergic drugs, and 5-alpha-reductase inhibitors. Anticholinergic drugs block the action of acetylcholine, a chemical messenger that sends signals to brain and eventually triggers abnormal bladder contractions associated with overactive bladder. Acetylcholine controls several functions of the body that are not under voluntary control such as sweating, pupil dilation, contraction of bladder muscles, digestion, and salivation. With regard to nephrological and urological disorders, anticholinergic drugs are mostly used for treating overactive bladder.

Anticholinergic drugs are recommended for a wide range of conditions including overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, vomiting, nausea, psychosis, and depression. Certain drugs such as oxybutynin and hyoscine are prescribed for their anticholinergic effect. Others exhibit anticholinergic activity not related to their primary mode of action, for example, ranitidine and carbamazepine. Increasing prevalence of neurological disorders drives the global Anticholinergic Drugs Market. However, there has been keen interest in the harm caused by drugs with anticholinergic effect. Certain side-effects of these drugs such as dry mouth, constipation, blurry vision, sedation, decreased sweating, difficulty urinating, decreased saliva, and memory impairment restrain the global anticholinergic drugs market.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34136

The global market for anticholinergic drugs, especially those used in nephrology and urology, is expected to expand at a moderate pace from 2017 to 2025. Some of the commonly prescribed anticholinergic drugs are Detrol (tolterodine) by Pfizer, Enablex (darifenacin) by Actavis, Vesicare (solifenacin) by Astellas Pharma US, Inc., Sanctura (trospium) by Allergan, Toviaz (fesoterodine) by Pfizer, and Ditropan XL (oxybutynin) by Janssen Pharmaceuticals. Recently, in July 2014, a research study conducted by the University of East Anglia revealed that long-term use of anticholinergic drugs could impact common physical functions of the patient.

The global anticholinergic drugs market can be segmented based on drugs into natural and synthetic or semisynthetic drugs. Natural anticholinergic drugs include Atropine and Hyoscine (Scopolamine). Based on mechanism of action, the global anticholinergic drugs market can be segmented into mydriatic, anti-spasmodic, anti-parkinson, anti-ulcer, anti-asthmatic, pre-anesthetic, drugs for motion sickness, and drugs for urinary incontinence. Based on distribution channel, the global anticholinergic drugs market can be segmented into hospital pharmacies, clinics, hospitals, retail pharmacies, and online pharmacies.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=34136

Geographically, the global anticholinergic drugs market can be segmented into five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. Asia Pacific held the leading market share, followed by North America, in 2016. These two regions are expected to retain their positions from 2017 to 2025. Rising prevalence of neurological complications and increasing government initiatives that appear to be moving toward shorter periods of patent exclusivity for new drug applications are some of the factors driving the market in these regions. Moreover, large population, increasing disposable income, and growing awareness among patients are a few factors driving the market in Asia Pacific. Europe and Middle East & Africa are likely to present significant growth opportunities to the anticholinergic drugs market during the forecast period. This is attributable to increasing geriatric population in these regions.

Key players operating in the global anticholinergic drugs market are Pfizer, Inc., Astellas Pharma US, Inc., Allergan plc, and Janssen Pharmaceuticals (a Johnson & Johnson company).

View Report -

https://www.transparencymarketresearch.com/anticholinergic-drugs-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticholinergic Drugs Market by Application, Trends and Growth Rate to 2025 here

News-ID: 955032 • Views: 195

More Releases from Transparency Market Research

Battery Alloys Market -Region Wise Analysis Of Top Players In By Its Types And A …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Battery Alloys Market for the 2023 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Battery Alloys Market
Torquing Tools Market Structure and Overview of Key Market Forces Propelling Mar …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Torquing Tools Market for the 2025 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Torquing Tools Market
Contract Drilling Market Emergence Of Advanced Technologies And Global Industry …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Contract Drilling Market for the 2023 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Contract Drilling Market over
Household Ventilation Electrical Appliance MarketDevelopment Trends, Key Manufac …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Household Ventilation Electrical Appliance Market for the 2023 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Household Ventilation

All 5 Releases


More Releases for Anticholinergic

Cervical Dystonia Treatment Market Emerging Economies Expected to Influence Grow …
Cervical dystonia/spasmodic torticollis is the involuntary muscular contraction of the neck, which leads to head twist. It is a rare neurological disorder that affects all age groups and most often it affects middle-aged people. Women are more susceptible to cervical dystonia compared to men. Muscular contractions of cervical dystonia can cause the head to twist in different directions, e.g., the chin towards the shoulder, chin straight up, ear toward the
Emerging Trends in Overactive Bladder Treatment Market With Industry Players lik …
The global overactive bladder treatment market is expected to register a CAGR of about 2.9% over the forecast period, 2018-2023. The overactive bladder treatments includes various therapies like, anticholinergics, mirabegron, etc., that are used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall leading to urinary urgency, frequency, nocturia, and urge-incontinence. Get Sample Copy of this report @ https://marketprognosis.com/sample-request/17149 Aging Population and Rising Incidence of Diseases Characterized
Nasal Spray Market Top Key Players Includes Bayer, J Pharmaceuticals, Aurena, In …
Global nasal spray market is expected to reach a CAGR of 6.3% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Also Global Nasal Spray Market,By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/ Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles),
Vertebrobasilar Insufficiency Treatment Market Segmentation By drug class Antihi …
Vertebrobasilar insufficiency is also called beauty parlor syndrome. It is defined as the temporaty decrease of blood flow in the posterior circulation of the brain. The most common symptoms are vertigo, dizziness, headaches, vomiting, ataxia, and weakness in both sides of the body. The main risk factors associated with vertebrobasilar insufficiency are arterial hypertension, obesity, and smoking. Vertebrobasilar insufficiency treatment is performed to examine and remove the plaques that are made
Anticholinergic Drugs Market Size(Volume & Value), Growth and Development Trends …
MarketResearchReports.Biz announces addition of new report "Anticholinergic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its database. The main objective of this report is to define, describe, and forecast the global “Anticholinergic Drugs” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the
Antispasmodic and Anticholinergic H2 Blocking Agents Market Plying for Significa …
The antispasmodics and anticholinergic are a group of medicines such as natural belladonna alkaloids which contains belladonna, atropine, scopolamine, hyoscyamine and other drugs. The antispasmodics and anticholinergic are generally used to relieve cramps and spasms of the intestine, stomach, and bladder. These drugs are used in the combination with antacids and other medicines for the treatment of ulcers, vomiting, nausea and motion sickness. The antispasmodics and anticholinergic drugs are also